TCL Archive NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units March 1, 2013
TCL Archive LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter. October 17, 2008
TCL Archive CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups March 6, 1981